相关实验视频
Updated: Sep 19, 2025
16:15
Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
20.9K
腎移植后的C3膠囊病變:一個單一中心的體驗
Jonathan Zuckerman1, Phuong-Thu Pham2, Meena Parakkal2
1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States.
World journal of transplantation
|June 19, 2025
概括
对于C3型血小板病 (C3G) 的移植结果很差,特别是在复发的情况下. 早期的eculizumab治疗显著改善了C3G患者移植后的移植存活率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 补充系统生物学 补充系统生物学
背景情况:
- C3球体病 (C3G) 是一种罕见的脏疾病,由补体系统调节失调引起.
- 在C3G患者中,移植与高复发率和低移植存活率有关.
- 对于移植后的C3G,终端补充抑制剂eculizumab的疗效尚未得到充分证实.
研究的目的:
- 评估C3G患者的移植结果.
- 评估eculizumab治疗对C3G移植接受者的移植存活率的影响.
主要方法:
- 移植接受者与活检确认C3G (1993-2023) 的回顾性研究.
- 对全移植功能,复发,移植失败以及使用eculizumab治疗的分析.
- 病理学家对活检结果的重新评估.
主要成果:
- 包括15名患者;14人患有复发性C3G,1人患有新的C3G.
- 中位数的移植存活时间为48个月;复发发生在7个月的中位数.
- 接受eculizumab治疗的患者的移植存活时间中位数为73个月 (5/7个功能植入物),而未接受治疗的患者的移植存活时间为22个月 (0/7个功能植入物,P=0.003).
结论:
- 移植后的C3G复发很常见,并且在没有治疗的情况下导致预后不佳.
- 未经治疗的C3G复发导致中位数全移植存活时间小于2年.
- 早期的eculizumab治疗可能会改善复发性C3G的移植结果.
相关概念视频
01:26Kidney Transplant II: Surgical Procedure
78
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78
01:28Kidney Transplant I: Introduction
65
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
65
01:16Kidney Transplant III: Nursing Management
85
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
85
01:29Acute Kidney Injury III: Clinical Manifestations
105
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
105
01:28Chronic Kidney Disease III: Interprofessional Care
84
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
84